Weight Loss
14
 min read

Does Protein Powder Cause Gynaecomastia? Evidence and Supplement Safety

Written by
Bolt Pharmacy
Published on
23/3/2026

Protein powder and gynaecomastia is a topic that generates considerable concern among men who use sports supplements. Gynaecomastia — the benign enlargement of glandular breast tissue in males — has several well-established causes, but whether protein powder is among them is frequently misunderstood. This article examines the clinical evidence, explores which supplement ingredients may carry a hormonal risk, and explains when breast tissue changes in men warrant a GP assessment. Understanding the distinction between protein itself and potentially problematic additives or contaminants is essential for making informed, safe choices.

Summary: Protein powder does not directly cause gynaecomastia, though certain supplement ingredients, contaminants, or associated substances such as anabolic steroids may disrupt hormonal balance and contribute to breast tissue enlargement in men.

  • Gynaecomastia results from an imbalance between oestrogen and androgen activity in breast tissue; standard protein powders are not recognised by NHS or NICE guidance as a cause.
  • Soy protein contains phytoestrogens (isoflavones), but meta-analyses show moderate intake does not meaningfully alter testosterone or oestradiol levels in healthy adult males.
  • Supplement contamination with undisclosed prohormones, SARMs, or DHEA — rather than protein itself — is a more plausible hormonal risk identified by UKAD and independent testing bodies.
  • Excess calorie intake from any source, including supplements, can increase body fat and raise aromatase activity, indirectly elevating oestrogen levels.
  • Choose third-party tested products certified by schemes such as Informed Sport (LGC) to reduce the risk of contamination with hormonal compounds.
  • Any firm, unilateral, or rapidly growing breast lump in a male should be assessed by a GP promptly; urgent two-week wait referral applies if cancer is suspected per NICE NG12.

What Is Gynaecomastia and What Causes It?

Gynaecomastia is benign glandular breast tissue enlargement in males caused by an oestrogen–androgen imbalance; established causes include medications, anabolic steroids, medical conditions, and obesity, with many cases classified as idiopathic.

Gynaecomastia is the benign enlargement of glandular breast tissue in males, affecting one or both breasts. It is distinct from pseudogynaecomastia, which refers to fat deposition in the chest area without true glandular growth. Gynaecomastia is relatively common, occurring in up to 60% of adolescent boys during puberty and in a notable proportion of older men, as described in NHS and NICE CKS guidance on the condition.

The underlying cause is typically an imbalance between oestrogen and androgen (testosterone) activity in breast tissue. Oestrogen stimulates glandular growth, whilst testosterone normally counteracts this effect. When this balance is disrupted — whether through elevated oestrogen, reduced testosterone, or increased sensitivity of breast tissue receptors — gynaecomastia can develop.

Established causes include:

  • Physiological changes during puberty, ageing, or the neonatal period

  • Medications such as anabolic steroids, anti-androgens, spironolactone, 5-alpha-reductase inhibitors (e.g., finasteride), oestrogens, cimetidine, ketoconazole, digoxin, and certain antiretrovirals (e.g., efavirenz)

  • Medical conditions including hypogonadism, hyperthyroidism, liver cirrhosis, and chronic kidney disease

  • Recreational drug use, including anabolic steroids; cannabis has been reported as a possible association in some cases, though the evidence remains inconsistent and of low certainty

  • Obesity, which increases peripheral conversion of androgens to oestrogens via aromatase enzymes in adipose tissue

In many cases, no identifiable cause is found, and the condition is classified as idiopathic. It is important to distinguish true gynaecomastia — which involves glandular tissue — from breast cancer, which, although rare in men, requires prompt investigation. Any unilateral, hard, or rapidly growing breast lump should be assessed by a GP without delay.

Can Protein Powder Contribute to Gynaecomastia?

There is no established direct causal link between standard protein powder consumption and gynaecomastia; the greater concern lies with undisclosed additives, contaminants, or co-used substances such as anabolic steroids.

The question of whether protein powder directly causes gynaecomastia is one that circulates widely in fitness communities, but the answer requires careful nuance. There is no established, direct causal link between standard protein powder consumption and gynaecomastia in the current clinical literature, and UK guidance from the NHS, NICE, and the MHRA does not identify standard protein powders as a cause of the condition.

Protein itself — whether from whey, casein, or plant-based sources — does not inherently disrupt hormonal balance in a way that would stimulate breast tissue growth. However, the concern is not entirely without basis. The issue lies less with protein as a macronutrient and more with what else may be present in certain supplements. The UK supplement industry, whilst subject to general food safety regulations enforced by the Food Standards Agency (FSA), does not require the same rigorous pre-market testing as licensed medicines regulated by the MHRA. This means that some products may contain undisclosed or poorly labelled ingredients that could theoretically influence hormone levels.

Additionally, some individuals use protein supplements alongside other performance-enhancing substances — including anabolic steroids or prohormones — which are well-documented causes of gynaecomastia. In these cases, the protein powder itself is not the causative agent.

It is also worth noting that a chronic excess of calories from any source, including supplements, can contribute to weight gain and increased adiposity. Greater fat mass raises aromatase activity, which in turn increases conversion of androgens to oestrogens. This is a consequence of overall excess energy intake rather than protein supplementation specifically.

Ingredient / Factor Found In Hormonal Concern Evidence Level Advice
Whey / casein protein Standard protein powders None identified; no phytoestrogens, no known oestrogenic mechanism No causal link established; not listed by NHS, NICE, or MHRA Considered low risk at normal serving sizes
Soy isoflavones (genistein, daidzein) Soy-based protein powders Weak oestrogen-receptor binding; phytoestrogen activity Meta-analyses (incl. J Nutrition 2021): no meaningful hormonal change at typical intakes; extreme intake uncertain Moderate intake likely safe; avoid very high daily doses long-term
Prohormones / DHEA Contaminated or mislabelled supplements Well-documented disruption of androgen–oestrogen balance; established cause of gynaecomastia Strong; consistently implicated in case reports and series Choose Informed Sport (LGC) certified products to reduce contamination risk
SARMs (selective androgen receptor modulators) Undisclosed contaminant in some supplements Hormonal disruption; may suppress endogenous testosterone Identified by UKAD and independent testing; not permitted in UK supplements Avoid unregulated online sources; report concerns to FSA or Trading Standards
Herbal additives (e.g., tribulus terrestris, fenugreek, ashwagandha) Protein blends with "testosterone support" claims Variable, poorly characterised interactions with sex hormone pathways Limited; evidence inconsistent and of low certainty Exercise caution; avoid products with proprietary blends obscuring quantities
Excess caloric intake (any source) High-volume supplement use contributing to weight gain Increased adiposity raises aromatase activity, converting androgens to oestrogens Established mechanism; not specific to protein powder Stick to recommended serving sizes; excess protein does not increase muscle gain
Anabolic steroids / prohormones (co-use) Used alongside protein supplements Well-documented cause of gynaecomastia; protein powder is not the causative agent Strong; listed by NHS and NICE as established cause Disclose all supplement and substance use to GP if gynaecomastia develops

Ingredients in Protein Supplements Linked to Hormonal Changes

Soy isoflavones, undisclosed prohormones or SARMs, and herbal additives with variable hormonal activity are the supplement-related ingredients most relevant to hormonal disruption, not protein itself.

Whilst protein itself is unlikely to cause gynaecomastia, certain ingredients commonly found in protein supplements warrant closer attention from a hormonal perspective.

Soy protein is perhaps the most discussed. Soy contains phytoestrogens — plant-derived compounds called isoflavones (primarily genistein and daidzein) — that can weakly bind to oestrogen receptors. The European Food Safety Authority (EFSA) reviewed the safety of soy isoflavones in 2015, primarily in the context of peri- and postmenopausal women at specific supplemental doses; its conclusions cannot be straightforwardly extrapolated to men or to all intake levels. In men, published meta-analyses (including a 2021 update in the Journal of Nutrition) have found that soy protein and isoflavone consumption at typical dietary intakes does not meaningfully alter serum testosterone or oestradiol levels. Individuals consuming very large quantities of soy-based protein powders over prolonged periods may nonetheless wish to exercise caution, as evidence at extreme intakes remains limited.

Herbal additives present in some protein blends — such as tribulus terrestris, fenugreek, or ashwagandha — are marketed for testosterone support but have variable and poorly characterised hormonal effects. Some herbal compounds may interact with sex hormone pathways in unpredictable ways.

Contamination and mislabelling are also relevant concerns. Independent testing organisations such as Informed Sport (operated by LGC) have identified cases where supplements contain undisclosed anabolic compounds or hormonal precursors. UK Anti-Doping (UKAD) similarly advises that supplement contamination is a recognised risk. These contaminants — rather than the protein itself — are more plausible contributors to hormonal disruption. Higher-risk adulterants include prohormones, selective androgen receptor modulators (SARMs), and dehydroepiandrosterone (DHEA).

Key ingredients and contaminants to be aware of include:

  • Soy isoflavones (phytoestrogens; risk is low at typical intakes but uncertain at very high doses)

  • Prohormones, SARMs, or DHEA (sometimes undisclosed; well-documented hormonal effects)

  • Herbal extracts with uncertain or variable hormonal activity

  • Permitted food additives used in supplements have undergone regulatory safety assessments by EFSA and JECFA and are not considered to carry oestrogenic risk at permitted intake levels

What the Evidence Says: Protein Powder and Breast Tissue

Clinical evidence consistently implicates anabolic steroids, prohormones, or contaminated products — not standard protein powders — in supplement-associated gynaecomastia; moderate soy intake does not significantly alter sex hormone levels in men.

The direct clinical evidence linking protein powder consumption to gynaecomastia is sparse. Published case reports and case series that associate supplements with gynaecomastia consistently implicate anabolic steroids, prohormones, or contaminated products rather than standard protein powders. UK guidance does not identify standard protein powders as a cause of gynaecomastia.

Regarding soy protein specifically, a 2010 case report published in Endocrine Practice described gynaecomastia in a man consuming very large quantities of soy milk daily, suggesting a possible phytoestrogen effect at extreme intake levels. However, this represents an exceptional case and cannot be generalised to typical protein powder use. Meta-analyses of controlled studies in men — including a 2021 analysis published in the Journal of Nutrition — have found that moderate soy protein and isoflavone consumption does not meaningfully alter serum oestrogen or testosterone levels in healthy adult males.

Whey protein, derived from cow's milk, contains no phytoestrogens and has no known mechanism by which it would stimulate breast tissue. Similarly, pea, rice, and hemp protein powders do not contain compounds with established oestrogenic activity at normal serving sizes.

It is also important to acknowledge that correlation does not imply causation. Many individuals who develop gynaecomastia whilst using protein supplements may simultaneously be using other substances, experiencing puberty-related hormonal shifts, gaining body weight, or taking medications — all of which are more plausible explanations.

When to Speak to a GP About Gynaecomastia

Consult a GP if you notice a firm or unilateral breast lump, nipple discharge, skin changes, or rapid breast enlargement; males with suspicious features should be referred urgently via the two-week wait pathway per NICE NG12.

Whilst gynaecomastia is often benign and self-limiting — particularly in adolescents — there are circumstances in which prompt medical assessment is essential. The NHS recommends consulting a GP if breast tissue enlargement is causing concern, pain, or psychological distress, or if it persists beyond two years in adolescents.

Seek a GP appointment if you notice:

  • A lump beneath the nipple or areola that is firm, hard, or fixed

  • Unilateral (one-sided) breast swelling, particularly in men aged 50 or over

  • Nipple discharge, skin changes, or dimpling

  • Rapid or progressive breast enlargement

  • Associated symptoms such as testicular pain, fatigue, or unexplained weight loss

During the consultation, your GP will take a full medical and medication history — including supplement use — and may arrange blood tests to assess hormone levels. Relevant investigations may include LH, FSH, testosterone, oestradiol, prolactin, thyroid function, hCG, SHBG, liver function tests, and renal function, as clinically indicated. If a testicular tumour is suspected, testicular examination and ultrasound may also be arranged. Imaging of the breast (ultrasound or, in secondary care, mammography) follows local breast clinic protocols and is used to differentiate glandular tissue from fat or to exclude malignancy.

If you are using protein supplements or other sports nutrition products, inform your GP of all supplements taken, including brand names and dosages where possible. This information can help identify potential contributing factors.

In line with NICE NG12 guidance on suspected cancer recognition and referral, any male with a suspicious breast lump — particularly with features such as a hard or fixed mass, skin or nipple changes, or unilateral presentation in an older man — should be referred urgently via the two-week wait pathway to exclude cancer. Male breast cancer accounts for less than 1% of all breast cancer cases in the UK but requires prompt assessment when suspected.

Safer Supplement Choices and Dietary Guidance

Choose third-party tested supplements certified by Informed Sport (LGC), avoid products with proprietary blends or testosterone-boosting herbal claims, and prioritise obtaining protein from a varied whole-food diet where possible.

For most people, a well-balanced diet provides sufficient protein without the need for supplementation. The UK Reference Nutrient Intake (RNI) for protein is approximately 0.75 g per kilogram of body weight per day for adults, as set out by the Department of Health and referenced by the British Dietetic Association (BDA). Those engaged in regular resistance or endurance training may have higher requirements — sports nutrition consensus guidance generally suggests 1.2–2.0 g per kilogram per day depending on training type and goals — though these needs can often be met through food. The NHS Eatwell Guide recommends obtaining protein from a variety of sources including lean meat, fish, eggs, dairy, legumes, and nuts.

If supplementation is chosen, the following practical guidance can help minimise risk:

  • Choose third-party tested products bearing certification from schemes such as Informed Sport (LGC), which screens for banned substances and contaminants and is widely recognised in the UK

  • Read ingredient labels carefully and avoid products containing proprietary blends that obscure individual ingredient quantities

  • Be cautious with products containing herbal additives or those marketed with testosterone-boosting claims, as these may carry a higher risk of hormonal interference

  • Avoid products purchased from unregulated online sources, where the risk of contamination or mislabelling is significantly higher

  • Stick to recommended serving sizes and avoid the misconception that more protein equates to greater muscle gain — excess protein is metabolised for energy or stored

  • Report concerns about unsafe food supplements to the FSA or your local authority trading standards service

UKAD also provides specific guidance for athletes on the risks of supplement contamination and advises caution when choosing any sports nutrition product.

If you are concerned about your diet, body composition, or supplement use, a referral to a registered dietitian — available through your GP or via self-referral in some NHS areas — can provide personalised, evidence-based guidance. No supplement should replace medical advice, and any new or unexplained physical changes should always be discussed with a qualified healthcare professional.

Frequently Asked Questions

Does whey protein cause gynaecomastia?

Whey protein contains no phytoestrogens and has no known mechanism by which it would stimulate breast tissue growth. Standard whey protein is not identified by NHS or NICE guidance as a cause of gynaecomastia.

Can soy protein powder affect hormone levels in men?

Meta-analyses, including a 2021 analysis in the Journal of Nutrition, found that moderate soy protein and isoflavone consumption does not meaningfully alter testosterone or oestradiol levels in healthy adult males. Very high intakes over prolonged periods carry more uncertainty.

When should a man see a GP about breast tissue enlargement?

A GP should be consulted if breast enlargement is firm, unilateral, rapidly growing, or accompanied by nipple discharge or skin changes. Per NICE NG12, any suspicious breast lump in a male warrants urgent referral via the two-week wait pathway to exclude cancer.


Disclaimer & Editorial Standards

The health-related content published on this site is based on credible scientific sources and is periodically reviewed to ensure accuracy and relevance. Although we aim to reflect the most current medical knowledge, the material is meant for general education and awareness only.

The information on this site is not a substitute for professional medical advice. For any health concerns, please speak with a qualified medical professional. By using this information, you acknowledge responsibility for any decisions made and understand we are not liable for any consequences that may result.

Any third-party brands or services referenced on this site are included for informational purposes only; we are entirely independent and have no affiliation, partnership, or collaboration with any companies mentioned.

Heading 1

Heading 2

Heading 3

Heading 4

Heading 5
Heading 6

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.

Block quote

Ordered list

  1. Item 1
  2. Item 2
  3. Item 3

Unordered list

  • Item A
  • Item B
  • Item C

Text link

Bold text

Emphasis

Superscript

Subscript

Book a discovery call

and discuss your eligibility for the Fella Program

Book your free call